Filter
345
Filtered Results: 345
Text search:
Kinshasa
Featured
Recommendations
37
New Publications
153
Language
Document type
No document type
211
Studies & Reports
67
Guidelines
26
Strategic & Response Plan
17
Situation Updates
14
Manuals
5
Fact sheets
3
Resource Platforms
1
Infographics
1
Countries / Regions
Congo, Democratic Republic of
185
Global
14
Africa
11
Central African Republic
9
Burkina Faso
7
Nigeria
6
Rwanda
5
Mozambique
5
Uganda
5
South Sudan
5
Liberia
5
West and Central Africa
4
Mali
4
Angola
4
Kenya
3
Guinea
3
Myanmar / Burma
3
Mexico
2
Ghana
2
Benin
2
Senegal
2
Malawi
2
Tanzania
2
East and Southern Africa
2
Zambia
2
Somalia
2
Colombia
1
Sierra Leone
1
Togo
1
Cameroon
1
Syria
1
Iran
1
Congo-Brazzaville
1
Afghanistan
1
Zimbabwe
1
Armenia
1
Guinea-Bissau
1
Venezuela
1
Middle East and North Africa
1
Côte d’Ivoire / Ivory Coast
1
South Africa
1
Namibia
1
Yemen
1
Palestine
1
Ethiopia
1
Chad
1
Libya
1
Indonesia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
191
Clinical Guidelines
31
Key Resources
13
Women & Child Health
12
Public Health
11
Capacity Building
4
Pharmacy & Technologies
3
Toolboxes
Ebola & Marburg
52
COVID-19
34
NTDs
24
Rapid Response
23
HIV
15
TB
13
Planetary Health
8
Mental Health
7
Disability
5
Natural Hazards
4
Refugee
3
NCDs
3
Conflict
3
Global Health Education
3
AMR
3
Cholera
2
Pharmacy
2
Health Financing Toolbox
2
Social Ethics
1
Caregiver
1
Zika
1
Polio
1
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
Project Paper to provide an additional grant for: Human Development Systems Strengthening Project (HDSSP)(P145965, H9360)
Accessed August 2018
recommandations à l’intention des agents de santé
Lancet Glob Health 2022; 10: e491–500
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
Le présent Atlas 2022 a été préparé par une équipe centrale du groupe organique Sous-Directrice régionale du Bureau régional de l’OMS pour l’Afrique sous la direction et l’orientation de Lindiwe Makubalo, directrice du groupe organique, et de Humphrey Cyprian Karamagi, chef de ...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Bull World Health Organ 2018;96:450–461 | doi: http://dx.doi.org/10.2471/BLT.17.206466
The aim of our study was to determine whether an intervention designed
to involve the male partners of pregnant women in Burkina Faso in facility-based maternity care influences care-seeking and healthy practi...
Antibiotic resistance (ABR) particularly hits resource poor countries, and is fuelled by irrational antibiotic (AB) prescribing. We surveyed knowledge, attitudes and practices of AB prescribing among medical students and doctors in Kisangani, DR Congo.
The aim of this paper is to map and critically analyse evidence of good practice in prevention and response to gender-based violence (GBV) in humanitarian contexts which can support humanitarian practitioners and policy makers to improve the quality of GBV programming in the field. The paper is stru...
L’ulcère de Buruli, une infection causée par Mycobacterium ulcerans, touche plus de 33 pays dans le monde, mais un peu moins de la moitié seulement de ces pays communiquent régulièrement des données sur la maladie à l’OMS.
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
